MRK Experimental Ebola Vaccine Granted Accelerated Review Status in US and EU

Merck & Co. (MRK) announced that its experimental Ebola vaccine, V920 (rVSVdeltaG-ZEBOV-GP, live attenuation) has received accelerated review … Full Article http://j.gs/5sTq

Click here to read full article